Stay updated on AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial
Sign up to get notified when there's something new on the AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial page.

Latest updates to the AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.3.2 shown; no other content changes are evident.SummaryDifference0.0%

- Check21 days agoChange DetectedPublications section now states that publications are automatically filled from PubMed and the revision label updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedA general funding-status notice was removed from the page; all study details and core content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check43 days agoChange DetectedMinor layout/formatting adjustments on the Study Details page; no changes to eligibility criteria, interventions, primary or secondary outcomes, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedAdded a government funding notice and updated version to v3.2.0; removed the term ‘Small cell lung carcinoma’ and reference to v3.1.0.SummaryDifference2%

- Check79 days agoChange DetectedUpdate term from 'Clear cell renal carcinoma' to 'Clear cell carcinoma of kidney' and bump version from v3.0.2 to v3.1.0.SummaryDifference0.2%

Stay in the know with updates to AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial page.